News Snapshot:
China likely to approve BioNTech’s COVID-19 vaccine by July – WSJ 7:39 AM (Reuters) -China is planning to authorize the COVID-19 vaccine developed by Germany's BioNTech SE by July, the Wall Street Journal reported on Friday, citing people familiar with the matter. If approved, it would become the first foreign COVID-19 vaccine to be authorized in the country. Chinese officials are reviewing clinical-trial data for the vaccine and are expected to authorize it for domestic use within the next 10 weeks, the report said. BioNTech did not immediately respond to a Reuters request for comment. The German drugmaker announced a...
